The Ambulatory Blood Pressure Monitoring (ABPM) Devices Market was valued at US$ 1.92 billion in 2025 and is projected to reach US$ 4.13 billion by 2034, expanding at a CAGR of 8.4% during 2026–2034. Market growth is being driven by the increasing prevalence of hypertension and cardiovascular diseases, growing awareness of out-of-office blood pressure monitoring, and the clinical value of obtaining multiple blood pressure readings throughout a patient’s daily activities and sleep. Technological advances in compact wearable monitors, connected healthcare, data analytics, and remote patient management are further supporting adoption.
What is driving the Ambulatory Blood Pressure Monitoring Devices Market?
The rising global burden of hypertension is a primary driver of demand for ABPM devices. Hypertension is a major cardiovascular risk factor, while conventional clinic-based blood pressure measurements may not always capture fluctuations occurring during normal daily activities. ABPM provides repeated measurements over an extended period, allowing healthcare professionals to evaluate blood pressure patterns beyond the clinical setting.
The increasing emphasis on early diagnosis and effective hypertension management is also encouraging healthcare providers to adopt more comprehensive monitoring approaches. ABPM can help assess variations such as nighttime blood pressure patterns and identify patients whose readings differ between clinical and everyday environments.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00002870
The shift toward preventive and personalized healthcare is another important growth factor. As healthcare systems focus increasingly on risk assessment and long-term disease management, continuous or repeated monitoring technologies are becoming more relevant to physicians and patients.
Which region leads the Ambulatory Blood Pressure Monitoring Devices Market?
North America is a major market for ABPM devices, supported by high awareness of hypertension management, established healthcare infrastructure, and strong adoption of connected medical technologies. The United States represents a significant opportunity because of its large hypertensive population and growing focus on remote and preventive cardiovascular care.
Europe also holds a substantial position in the market. The region benefits from established clinical practices, increasing awareness of ambulatory monitoring, and healthcare systems that emphasize early detection and management of cardiovascular risk factors. Demand for compact and patient-friendly monitoring devices is supporting continued development.
Asia Pacific is expected to witness strong growth through 2034. Rising healthcare expenditure, expanding diagnostic infrastructure, increasing hypertension prevalence, and improving access to cardiovascular care are creating opportunities across countries such as China, India, Japan, and South Korea. Growing awareness among healthcare professionals and patients can further accelerate adoption.
Which segment leads the Ambulatory Blood Pressure Monitoring Devices Market?
Portable ABPM monitors represent a core segment of the market because they allow patients to undergo blood pressure assessment while continuing normal daily activities. These devices typically combine a wearable monitor with an inflatable cuff and recording system that automatically collects measurements at predetermined intervals.
The market is also evolving toward digital and connected monitoring technologies. Devices capable of transferring collected information to computers, mobile applications, or cloud-based platforms can support more efficient data analysis and remote clinical workflows.
Another important area is software and data analytics. As ABPM systems generate numerous readings over extended monitoring periods, intuitive software can help clinicians organize measurements, identify patterns, and generate reports. Integration with electronic health records and remote care platforms may further improve workflow efficiency.
Which companies are prominent in the Ambulatory Blood Pressure Monitoring Devices Market?
The competitive landscape includes established medical device manufacturers and specialists in blood pressure monitoring technologies. Prominent companies include:
- Spacelabs Healthcare, Inc.
- Welch Allyn, Inc.
- SunTech Medical, Inc.
- Bosch + Sohn GmbH u. Co. KG
- SCHILLER AG
- GE HealthCare Technologies Inc.
- Rudolf Riester GmbH
- Vaso Corporation
- BPL Medical Technologies Pvt. Ltd.
- OMRON Healthcare Co., Ltd.
These companies compete through device accuracy, portability, patient comfort, connectivity, software capabilities, and integration with broader cardiovascular monitoring solutions. This company list represents prominent market participants and is not intended to indicate revenue-based market-share rankings.
What is changing in the Ambulatory Blood Pressure Monitoring Devices Market in 2026?
Connectivity, miniaturization, patient comfort, and integration with digital healthcare platforms are among the key trends shaping the ABPM industry. Manufacturers are focusing on making devices smaller, lighter, and easier for patients to wear during everyday activities and sleep.
Connected monitoring is also becoming increasingly important. ABPM systems that support digital data transfer can help healthcare providers review measurements remotely and incorporate blood pressure information into broader chronic disease management programs.
Data analytics is another emerging area of innovation. Instead of relying only on individual blood pressure readings, modern systems can organize large datasets to provide a more comprehensive view of daily and nighttime blood pressure patterns. Integration with digital health platforms could strengthen the role of ABPM in personalized hypertension management.
Purchase a Copy of this report: https://www.theinsightpartners.com/buy/TIPRE00002870
What are the major investment opportunities?
The growing focus on hypertension prevention and digital cardiovascular care creates attractive opportunities across ABPM devices, connected monitoring, analytics software, and remote patient management. Companies developing comfortable wearable systems with reliable connectivity and easy-to-use clinical reporting tools may benefit from increasing demand for out-of-office blood pressure assessment.
Emerging markets also present significant opportunities as healthcare infrastructure improves and awareness of hypertension increases. Expanding access to diagnostic technologies, physician education, and affordable monitoring devices can support adoption across developing healthcare systems.
Also Available in: Korean | German | Japanese | French | Chinese | Italian | Spanish
Related Reports:
Mammography Detectors Market Size, Share & Demand by 2034
Mass Spectrometry Market Size, Share & Forecast by 2034
About Us
The Insight Partners is a one-stop provider of actionable industry research and intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Food and Beverages, Consumer Goods, and Chemicals and Materials.
Contact Us
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
E-mail : sales@theinsightpartners.com
